Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment

<i>Issue:</i> The impact of neurological disorders is recognised globally, with one in six people affected in their lifetime and few treatments to slow or halt disease progression. This is due in part to the increasing ageing population, and is confounded by the high failure rate of tran...

Full description

Bibliographic Details
Main Authors: Samantha L. Eaton, Fraser Murdoch, Nina M. Rzechorzek, Gerard Thompson, Claudia Hartley, Benjamin Thomas Blacklock, Chris Proudfoot, Simon G. Lillico, Peter Tennant, Adrian Ritchie, James Nixon, Paul M. Brennan, Stefano Guido, Nadia L. Mitchell, David N. Palmer, C. Bruce A. Whitelaw, Jonathan D. Cooper, Thomas M. Wishart
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/17/2641
_version_ 1827666848002342912
author Samantha L. Eaton
Fraser Murdoch
Nina M. Rzechorzek
Gerard Thompson
Claudia Hartley
Benjamin Thomas Blacklock
Chris Proudfoot
Simon G. Lillico
Peter Tennant
Adrian Ritchie
James Nixon
Paul M. Brennan
Stefano Guido
Nadia L. Mitchell
David N. Palmer
C. Bruce A. Whitelaw
Jonathan D. Cooper
Thomas M. Wishart
author_facet Samantha L. Eaton
Fraser Murdoch
Nina M. Rzechorzek
Gerard Thompson
Claudia Hartley
Benjamin Thomas Blacklock
Chris Proudfoot
Simon G. Lillico
Peter Tennant
Adrian Ritchie
James Nixon
Paul M. Brennan
Stefano Guido
Nadia L. Mitchell
David N. Palmer
C. Bruce A. Whitelaw
Jonathan D. Cooper
Thomas M. Wishart
author_sort Samantha L. Eaton
collection DOAJ
description <i>Issue:</i> The impact of neurological disorders is recognised globally, with one in six people affected in their lifetime and few treatments to slow or halt disease progression. This is due in part to the increasing ageing population, and is confounded by the high failure rate of translation from rodent-derived therapeutics to clinically effective human neurological interventions. Improved translation is demonstrated using higher order mammals with more complex/comparable neuroanatomy. These animals effectually span this translational disparity and increase confidence in factors including routes of administration/dosing and ability to scale, such that potential therapeutics will have successful outcomes when moving to patients. Coupled with advancements in genetic engineering to produce genetically tailored models, livestock are increasingly being used to bridge this translational gap. <i>Approach:</i> In order to aid in standardising characterisation of such models, we provide comprehensive neurological assessment protocols designed to inform on neuroanatomical dysfunction and/or lesion(s) for large animal species. We also describe the applicability of these exams in different large animals to help provide a better understanding of the practicalities of cross species neurological disease modelling. <i>Recommendation:</i> We would encourage the use of these assessments as a reference framework to help standardise neurological clinical scoring of large animal models.
first_indexed 2024-03-10T01:57:26Z
format Article
id doaj.art-f845c8ece4d54008a0fb30760828a416
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T01:57:26Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-f845c8ece4d54008a0fb30760828a4162023-11-23T12:54:26ZengMDPI AGCells2073-44092022-08-011117264110.3390/cells11172641Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical AssessmentSamantha L. Eaton0Fraser Murdoch1Nina M. Rzechorzek2Gerard Thompson3Claudia Hartley4Benjamin Thomas Blacklock5Chris Proudfoot6Simon G. Lillico7Peter Tennant8Adrian Ritchie9James Nixon10Paul M. Brennan11Stefano Guido12Nadia L. Mitchell13David N. Palmer14C. Bruce A. Whitelaw15Jonathan D. Cooper16Thomas M. Wishart17Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKMedical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UKCentre for Clinical Brain Sciences, University of Edinburgh, Chancellor’s Building, 49 Little France Crescent, Edinburgh EH16 4SB, UKRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKThe Large Animal Research & Imaging Facility, Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKThe Large Animal Research & Imaging Facility, Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKThe Large Animal Research & Imaging Facility, Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKThe Large Animal Research & Imaging Facility, Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKTranslational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UKRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKFaculty of Agriculture and Life Sciences, Lincoln University, P.O. Box 85084, Lincoln 7647, New ZealandFaculty of Agriculture and Life Sciences, Lincoln University, P.O. Box 85084, Lincoln 7647, New ZealandRoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UKDepartments of Pediatrics, Genetics, and Neurology, Washington University School of Medicine in St. Louis, 660 S Euclid Ave, St. Louis, MO 63110, USARoyal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, UK<i>Issue:</i> The impact of neurological disorders is recognised globally, with one in six people affected in their lifetime and few treatments to slow or halt disease progression. This is due in part to the increasing ageing population, and is confounded by the high failure rate of translation from rodent-derived therapeutics to clinically effective human neurological interventions. Improved translation is demonstrated using higher order mammals with more complex/comparable neuroanatomy. These animals effectually span this translational disparity and increase confidence in factors including routes of administration/dosing and ability to scale, such that potential therapeutics will have successful outcomes when moving to patients. Coupled with advancements in genetic engineering to produce genetically tailored models, livestock are increasingly being used to bridge this translational gap. <i>Approach:</i> In order to aid in standardising characterisation of such models, we provide comprehensive neurological assessment protocols designed to inform on neuroanatomical dysfunction and/or lesion(s) for large animal species. We also describe the applicability of these exams in different large animals to help provide a better understanding of the practicalities of cross species neurological disease modelling. <i>Recommendation:</i> We would encourage the use of these assessments as a reference framework to help standardise neurological clinical scoring of large animal models.https://www.mdpi.com/2073-4409/11/17/2641neurological diseaselarge animal modelclinical assessmentmodel selection criteria
spellingShingle Samantha L. Eaton
Fraser Murdoch
Nina M. Rzechorzek
Gerard Thompson
Claudia Hartley
Benjamin Thomas Blacklock
Chris Proudfoot
Simon G. Lillico
Peter Tennant
Adrian Ritchie
James Nixon
Paul M. Brennan
Stefano Guido
Nadia L. Mitchell
David N. Palmer
C. Bruce A. Whitelaw
Jonathan D. Cooper
Thomas M. Wishart
Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
Cells
neurological disease
large animal model
clinical assessment
model selection criteria
title Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
title_full Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
title_fullStr Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
title_full_unstemmed Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
title_short Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment
title_sort modelling neurological diseases in large animals criteria for model selection and clinical assessment
topic neurological disease
large animal model
clinical assessment
model selection criteria
url https://www.mdpi.com/2073-4409/11/17/2641
work_keys_str_mv AT samanthaleaton modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT frasermurdoch modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT ninamrzechorzek modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT gerardthompson modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT claudiahartley modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT benjaminthomasblacklock modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT chrisproudfoot modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT simonglillico modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT petertennant modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT adrianritchie modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT jamesnixon modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT paulmbrennan modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT stefanoguido modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT nadialmitchell modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT davidnpalmer modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT cbruceawhitelaw modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT jonathandcooper modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment
AT thomasmwishart modellingneurologicaldiseasesinlargeanimalscriteriaformodelselectionandclinicalassessment